Cosentyx and Taste - impaired - a phase IV clinical study of FDA data
Summary:
Taste - impaired is found among people who take Cosentyx, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Cosentyx and have Taste - impaired. It is created by eHealthMe based on reports of 170,593 people who have side effects when taking Cosentyx from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
170,593 people reported to have side effects when taking Cosentyx.
Among them, 250 people (0.15%) have Taste - impaired.
What is Cosentyx?
Cosentyx has active ingredients of secukinumab. It is often used in psoriatic arthritis. eHealthMe is studying from 141,651 Cosentyx users for its effectiveness, alternative drugs and more.
What is Taste - impaired?
Taste - impaired is found to be associated with 3,462 drugs and 2,969 conditions by eHealthMe.
Number of Cosentyx and Taste - impaired reports submitted per year:

Time on Cosentyx when people have Taste - impaired *:
Gender of people who have Taste - impaired when taking Cosentyx*:
Age of people who have Taste - impaired when taking Cosentyx *:
Common drugs people take besides Cosentyx *:
Common side effects people have besides Taste - impaired *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Cosentyx and have Taste - impaired?
Check whether Taste - impaired is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Taste - impaired and when was it recovered:
Expand to all the drugs that have ingredients of secukinumab:
Alternative drugs to, pros and cons of Cosentyx:
- Cosentyx (141,651 reports)
Common Cosentyx side effects:
- Drug ineffective: 24,399 reports
- Psoriasis (immune-mediated disease that affects the skin): 21,919 reports
- Joint pain: 16,485 reports
- Pain: 14,000 reports
- Rashes (redness): 9,379 reports
- Malaise (a feeling of general discomfort or uneasiness): 7,934 reports
- Fatigue (feeling of tiredness): 7,884 reports
- Itching: 7,536 reports
Browse all side effects of Cosentyx:
a b c d e f g h i j k l m n o p q r s t u v w x y zTaste - impaired treatments and more:
- Taste - impaired (71,189 reports)
COVID vaccines that are related to Taste - impaired:
- Taste - impaired in Moderna COVID Vaccine
- Taste - impaired in Pfizer BioNTech Covid Vaccine
- Taste - impaired in Johnson and Johnson Covid Vaccine
Common drugs associated with Taste - impaired:
- Lunesta: 4,104 reports
- Aspirin: 3,260 reports
- Sutent: 2,289 reports
- Metformin: 2,128 reports
- Lisinopril: 2,101 reports
- Amlodipine: 1,992 reports
- Omeprazole: 1,948 reports
- Synthroid: 1,920 reports
- Chantix: 1,829 reports
- Prednisone: 1,763 reports
All the drugs that are associated with Taste - impaired:
- Taste - impaired (3,462 drugs)
Common conditions associated with Taste - impaired:
- High blood pressure: 3,256 reports
- Insomnia: 2,683 reports
- Hepatitis c: 2,469 reports
- High blood cholesterol: 2,114 reports
- Depression: 1,748 reports
- Pain: 1,741 reports
- Quit smoking: 1,728 reports
- Rheumatoid arthritis: 1,716 reports
All the conditions that are associated with Taste - impaired:
- Taste - impaired (2,969 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on secukinumab (the active ingredients of Cosentyx) and Cosentyx (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vitamins and Muscle Spasms - a second ago
- How effective is Baclofen for Gastroesophageal Reflux Disease? - 4 seconds ago
- Carbatrol and Tachycardia Aggravated - 33 seconds ago
- How effective is Acanya for Acne? - 47 seconds ago
- How effective is Yasmin for Acne? - 49 seconds ago
- Captopril and Concomitant Disease Aggravated - 53 seconds ago
- Botox Cosmetic and Nausea And Vomiting - 56 seconds ago
- Parkinson'S Disease in Claritin, how severe and when it was recovered? - a minute ago
- Tolterodine and Rabeprazole drug interaction - a minute ago
- Astelin and Prochlorperazine drug interaction - a minute ago